Media Trust Score85%

AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of …

NORTH CHICAGO, Ill., Sept. 19, 2022 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced the European Medicines Agency’s (EMA) Committee for …

  • You already voted!
  • Read More